Background: Children with pharmacoresistant epilepsy usually receive ketogenic diet (KD) as an inpatient, which makes it an expensive treatment.
Objective: To compare the effectiveness, safety, and costs of outpatient versus inpatient initiated KD.
Design: Retrospective observational non-inferiority study.